Stanford Clinical Trials
Stanford clinician scientists are engaged in a wide variety of clinical trials investigating new approaches to preventing and treating conditions and diseases. The variety of therapies being studied range from new pharmaceutical drugs and medical devices to behavioral and biotechnology therapies. These trials are done in close collaboration with scientists and physicians from many areas of expertise across Stanford University. To insure the highest ethical standards are maintained the Institutional Review Board (IRB) is responsible for oversight of all studies.
National Clinical Trials
ClinicalTrials.gov, a service of the U.S. National Institutes of Health, is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.
National Cancer Institute Clinical Trials
The U.S. National Institutes of Health National Cancer Center offers search services to find trials that are currently accepting patients, results of trials, educational materials, and information for research teams.
Stanford Cancer Center
The clinician scientists of the Stanford Cancer Center are engaged in more than 250 clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.
The mission of Center Watch is to be the leading source of news, directories, analysis, and proprietary market research for clinical research professionals and patients. CenterWatch is committed to providing patients and their advocates information on clinical trials, specific drugs, as well as other essential health and educational resources.